J Bone Metab.  2014 Nov;21(4):257-262. 10.11005/jbm.2014.21.4.257.

Vitamin D Status and Response to Initial Vitamin D Supplementation in Korean Women with Osteoporosis

• Kim JJ
• Kim SS
• Yoon SJ
• Jung JG
• Kim JS

• KMID: 2170053
• DOI: http://doi.org/10.11005/jbm.2014.21.4.257

Abstract

BACKGROUND
The aim of this study is to evaluate whether the optimal vitamin D level is achieved after taking recommended dose in vitamin D deficient patients.
METHODS
This was a retrospective study. Women (n=52) first diagnosed with osteoporosis were recruited in outpatient clinic. They were recommended to be exposed to sun light for more than 30 min a day. Subjects were divided into 3 groups according to serum 25-hydroxy-vitamin D3 (25-[OH]D3) status: deficiency (less than 20 ng/mL), insufficiency (20-30 ng/mL) and sufficiency (30 ng/mL or more). Insufficient and sufficient patients received the recommended dose (1,000 IU/day) but deficient patients received recommended or double dose (1,800-2,000 IU/day). We compared 25-(OH)D levels at baseline and after vitamin D supplementation for 3 months.
RESULTS
Median (interquartile range) serum 25-(OH)D concentration at baseline was 15.10 (13.30-16.97) ng/mL and the proportion of deficient, insufficient and sufficient groups were 69.2%, 23.1%, and 7.7% respectively. The optimal 25-(OH)D level (30 ng/mL or more) was achieved in 83.3% of insufficient patients with the recommended dose and was did in 55.6% of deficient patients with recommended dose (P=0.117). However, 88.9% of the deficient patient with double dose achieved optimal level (P=0.030).
CONCLUSIONS
About 44% of vitamin D deficient patients did not attain the optimal level of serum 25-(OH)D despite recommended daily intake of vitamin D to 1,000 IU in patients with osteoporosis. Follow-up of serum 25-(OH)D levels may be required for vitamin D supplementation in vitamin D deficient patients with osteoporosis.

Keyword

25-hydroxyvitamin D3; Osteoporosis; Vitamin D; Women

MeSH Terms

Ambulatory Care Facilities
Calcifediol
Female
Follow-Up Studies
Humans
Osteoporosis*
Recommended Dietary Allowances
Retrospective Studies
Solar System
Vitamin D*
Calcifediol
Vitamin D

Reference

1. Holick MF. Vitamin D deficiency. N Engl J Med. 2007; 357:266–281.

2. Khazai N, Judd SE, Tangpricha V. Calcium and vitamin D: skeletal and extraskeletal health. Curr Rheumatol Rep. 2008; 10:110–117.

3. Parfitt AM. Osteomalacia and related disorders. In : Avioli LV, Krane SM, editors. Metabolic bone disease and clinically related disorders. Philadelphia, PA: W.B. Saunders Company;1990. p. 329–396.

4. Sahota O, Masud T, San P, et al. Vitamin D insufficiency increases bone turnover markers and enhances bone loss at the hip in patients with established vertebral osteoporosis. Clin Endocrinol (Oxf). 1999; 51:217–221.

5. Malavolta N, Pratelli L, Frigato M, et al. The relationship of vitamin D status to bone mineral density in an Italian population of postmenopausal women. Osteoporos Int. 2005; 16:1691–1697.

6. The Korean Society of the Bone Metabolism. Physician's guide for diagnosis & treatment of osteoporosis. Seoul: Mincom;2008.

7. Dawson-Hughes B, Heaney RP, Holick MF, et al. Estimates of optimal vitamin D status. Osteoporos Int. 2005; 16:713–716.

8. Choi EY. 25(OH)D status and demographic and lifestyle determinants of 25(OH)D among Korean adults. Asia Pac J Clin Nutr. 2012; 21:526–535.

9. Bischoff-Ferrari HA, Shao A, Dawson-Hughes B, et al. Benefit-risk assessment of vitamin D supplementation. Osteoporos Int. 2010; 21:1121–1132.

10. Cannell JJ, Hollis BW. Use of vitamin D in clinical practice. Altern Med Rev. 2008; 13:6–20.

11. Ryu OH, Lee S, Yu J, et al. A prospective randomized controlled trial of the effects of vitamin D supplementation on long-term glycemic control in type 2 diabetes mellitus of Korea. Endocr J. 2014; 61:167–176.

12. Ryu OH, Chung W, Lee S, et al. The effect of high-dose vitamin D supplementation on insulin resistance and arterial stiffness in patients with type 2 diabetes. Korean J Intern Med. 2014; 29:620–629.

13. Ivorra J, Valls E, Fernández-Llanio Comella N, et al. Vitamin D status in osteoporotic postmenopausal women taking oral recommended vitamin D supplementation. Med Clin (Barc). 2012; 138:199–201.

14. Gallagher JC, Sai A, Templin T 2nd, et al. Dose response to vitamin D supplementation in postmenopausal women: a randomized trial. Ann Intern Med. 2012; 156:425–437.